ImmunityBio, Inc. IBRX

Set alert

8.29 USD +0.34 (+4.28%)

At closeNov 3, 2026, 4:00 PM EST

8.25 -0.04 -0.48%

After hours · Nov 3, 4:00 PM ET

7.97 Day range 8.43

1.95 52-week range 12.43

Held by insiders 62.15%

Held by institutions 19.94%

Float held by institutions 52.70%

Institutions 511

Top institutional holders
Holder	% held	Shares	Value	Reported
Blackrock Inc.	3.22%	34,083,262	282.55M	Jun 29, 2026
State Street Corporation	2.02%	21,398,438	177.39M	Jun 29, 2026
Vanguard Portfolio Management LLC	1.69%	17,863,911	148.09M	Jun 29, 2026
Vanguard Capital Management LLC	1.48%	15,691,579	130.08M	Jun 29, 2026
Shaw D.E. & Co., Inc.	1.09%	11,551,019	95.76M	Jun 29, 2026
Two Sigma Investments, LP	1.05%	11,097,106	92.00M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	1.10%	11,702,382	97.01M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund	1.09%	11,597,491	96.14M	Jun 29, 2026
iShares Trust-iShares Russell 2000 ETF	0.94%	9,991,183	82.83M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund	0.79%	8,399,273	69.63M	Jun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund	0.46%	4,852,894	40.23M	Jun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	0.40%	4,230,859	35.07M	Aug 30, 2026

IBRX insiders
Insider	Relation	Latest transaction	Date	Shares held
ADCOCK RICHARD	Chief Executive Officer	Conversion of Exercise of derivative security	Feb 19, 2026	560,344
COHEN CHERYL L	Director	Sale	Oct 1, 2026	100,309
REGAN LAUER	Officer	Conversion of Exercise of derivative security	Feb 19, 2026	115,875
SACHS DAVID C	Chief Financial Officer	Conversion of Exercise of derivative security	Feb 19, 2026	300,143
SELECKY CHRISTOBEL E.	Director	Sale	Jun 30, 2026	0
SIMON BARRY J. M.D.	Director	Sale	Oct 4, 2026	2,777,790

Held by funds